Drug recall · February 6, 2013
Temodar recall
Why: Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033
- Lots / codes
Lot: 0NCW005, Exp 02/2013
- Quantity
- 17,169 Packages
- Company
- Schering-Plough Products, LLC, Las Piedras, PR
- Distribution
- Nationwide and Puerto Rico
- Initiated
- December 12, 2012 · Voluntary: Firm initiated
- Classified
- January 30, 2013
- Reported
- February 6, 2013
- Ended
- January 3, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temozolomide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.